Our results show that the expression levels of AM, CRLR, RAMP1, RAMP2, and RAMP3 are higher in gastric cancer tissues than in the adjacent non-tumor gastric tissues, and the patients with the lower expression levels of AM lived longer (p=0.0258). Here, RAMP3 is linked to neoplasm.